Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
In the present investigation, a series of 5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolyl-2-toluidinomethanethione and 5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolyl-2-methoxyanilinomethanethione were synthesized and were tested for their antimycobacterial activity in vitro against isoniazid (INH) resistant Mycobacteium tuberculosis (INHR-MTB). Compound 6i was found to be the most potent derivative of the series with an MIC value of 0.90 mg/mL. When compared to INH, compound 6i was ca. 2-fold more active against INH resistant Mycobacterium tuberculosis (INHR-MTB).